Abstract
Glycyrrhizic acid (GA) is the substance with the highest content of triterpenoid saponins that can be extracted from licorice, and has anti-inflammatory, neuroprotective, and anticancer functions, among others. The aim of this study was to investigate the protective effect of GA on cognitive decline in middle-aged mice and explore its mechanisms. We injected GA by the tail vein of C57BL/6 mice and measured their cognitive levels using the Morris water maze. The Morris water maze results demonstrated that GA improved learning and memory abilities in middle-aged mice. Furthermore, the RNA-sequencing and flow cytometric analyses revealed that GA could increase T and B cells. We then confirmed the relationship between cognition and the immune system in the immune-deficient B-NDG mouse model. Our results suggest that GA improves cognition in aging mice by regulating T/B cell proliferation.
Keywords: glycyrrhizic acid, learning and memory, cognition, T cells, B cells
Introduction
Cognitive decline is a characteristic of human aging, and age-related deterioration of learning and memory also occurs in rats (Frick et al., 2000). Therefore, age-related decline in spatial memory has been extensively studied in rats. These studies have shown that deteriorations in spatial learning and memory functions can be observed after 4–5 months of age (Shoji et al., 2016), and these functions decline from 12 months of age in C57BL/6J mice (Bach et al., 1999). Therefore, preventing age-related decline in middle-aged mice has important applications for humans.
Licorice is the root of Glycyrrhiza glabra L. (Leguminosae), which grows in various warm climates such as the Middle East, Asia, and Southern Europe. It is one of the oldest known medicinal herbs and is referred to as “the father of herbal medicine.” Glycyrrhizic acid (GA) (Figure 1A), a triterpenoid saponin, is a major component of licorice. It has a variety of pharmacological activities such as anti-inflammatory, antioxidant, anticancer, neuroprotective, and immune-regulatory effects, among others (Wang et al., 2020). Previous studies indicated that GA produces robust neuroprotection via the modulation of anti-apoptotic and pro-apoptotic factors, primarily through the ERK signaling pathway and its anti-inflammatory properties against high-mobility group box 1 phosphorylation and the suppression of inflammatory cytokine induction (Gong et al., 2012; Kim et al., 2012; Teng et al., 2014). These results were based on pathological models. Although numerous pathways have been implicated in the neuroprotective effects of GA, the molecular mechanisms are not yet completely understood. In this study, we aimed to investigate the effects of GA in preventing age-related cognitive disorders, and the underlying molecular mechanisms.
Materials and Methods
Reagents
Glycyrrhizic acid (GA) was obtained from TAUTO (Sichuan, China). 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI), lysis buffer, and all antibodies used for flow cytometry were purchased from BD Pharmingen (San Diego, CA). Information regarding the antibodies used in this study is listed in the Table 1.
TABLE 1.
Reagent or resource | Source | Identifier |
Antibodies | ||
CD3e | BD Biosciences | Cat# 553063 |
CD45R/B220 | BD Biosciences | Cat# 553087 |
CD49b | BD Biosciences | Cat# 558295 |
CD4 | BD Biosciences | Cat# 550954 |
CD8a | BD Biosciences | Cat# 563152 |
CD45 | BD Biosciences | Cat# 566439 |
CD3 | BD Biosciences | Cat# 560590 |
CD44 | BD Biosciences | Cat# 553134 |
CD62l | BD Biosciences | Cat# 560516 |
CD45R/B220 | BD Biosciences | Cat# 553087 |
CD138 | BD Biosciences | Cat# 558626 |
CD27 | BD Biosciences | Cat# 558754 |
Chemicals | ||
Glycyrrhizic acid | TAUTO | Cat# 1405-86-3 |
Lysing Buffer | BD Biosciences | Cat# 555899 |
DAPI | BD Biosciences | Cat# 564907 |
TRIzol | Gibco | Cat# 15596018 |
the Prime ScriptTM RT Master Mix (Perfect Real Time) | Takara | Cat# RR036A |
SYBR Green fluorescent dye | BioRad | Cat# 172-5120 |
PBS | Gibco | Cat# 10010049 |
PFA | Sigma | Cat# 158127 |
Nestin | Millipore | Cat# MAB5326 |
SOX2 | Abcam | Cat# ab93689 |
Experimental model | ||
B-NDG | Biocytogen | B-CM-002 |
C57BL/6 | SLACCAS | |
Oligonucleotides | ||
Gene | Forward primer | Reverse primer |
CD3e | CTGCTACACACCAG CCTCAA | GTAATAAATGACCATCA GCAAGC |
CD45R/B220 | CCAGTGATGCTACCA CAACG | CAATCCTCATTTCCACAC TTAGC |
β-actin | TATTGGCAACGAGC GGTTC | ATGCCACAGGATTCCA TACCC |
Animals
Both 8-week-old and 8-month-old female SPF C57BL/6 mice were obtained from Shanghai SLACCAS Co., Ltd. (Shanghai, China). 8-week-old female SPF B-NDG mice were obtained from Jiangsu Biocytogen Co., Ltd. (Nantong, China). All mice were housed five per cage and maintained on a 12 h light/dark schedule and allowed free access to food and water following a protocol approved by the Animal Research Committee of Tongji University School of Medicine, China. GA was administrated by tail vein every other day for 42 days. Control mice were tail vein administrated the same volume of PBS.
qRT-PCR Analysis
Total RNA was isolated using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, United States), and cDNA was prepared using the Prime ScriptTM RT Master Mix (Perfect Real Time) (Takara, Dalian, China) according to the manufacturer’s protocols. The qRT-PCR reactions were performed using SYBR green fluorescent dye (BioRad). Primer sequences are listed in the Table 1.
The Morris Water Maze Task
The Morris water maze consists of a round, black pool of 120 cm in diameter and 31 cm deep containing water at 23 ± 1°C. The escape platform (11 cm in diameter, adjustable height) was placed in the center of one quadrant of the pool and hidden below the water surface at 1.5 cm deep. Various prominent visual cues were placed around the pool and remained in the same position during training and testing periods. Each group was trained for 6 consecutive days from four locations and then tested on day 6 with a new direction, removing the hidden platform and allowing free swimming for 60 s. The escape latencies from the water, and the distance traveled to find the platform was recorded using video-animal tracking software.
Novel Object Recognition
Each mouse was habituated to an empty novel object recognition (NOR) open-field box for two 10 min test sessions 24 h apart. Twenty-four hours after the last habituation session, mice were subjected to training during a 10 min exposure session of two identical, non-toxic objects (metal or hard plastic items) in the open-field box. The time spent exploring each object was recorded using ObjectScan software (Clever Sys. Inc., Reston, VA); an area 2 cm2 surrounding the object was defined, so that nose entries within 2 cm of the object was recorded as time exploring the object. After the training session, the animal was returned to its home cage. After a retention interval of 1 h (Zhang et al., 2016), the animal was returned to the arena in which two objects, one identical to the familiar object but previously unused (to prevent olfactory cues and prevent the necessity of washing objects during experimentation) and one novel object. The animal was allowed to explore for 10 min, during which the amount of time exploring each object was recorded. Objects were randomized and counterbalanced across animals. Animals that spent <7 s exploring the objects during the 10 min test session were omitted from the analysis. Objects and arenas were thoroughly cleaned with 70% isopropanol between trials. For the novel object recognition tests, the time spent exploring the novel object (familiar vs. novel) was reported as the recognition index, and was calculated using the following formula: [(time exploring specified object)/(time exploring novel object + time exploring familiar object)] × 100 (Taglialatela et al., 2009). Statistical analysis of NOR data is done by first performing an one-sample t-test to determine if the mean percentage exploration time is significantly different from a theoretical mean of 0.5000. This is followed by one-way ANOVA to determine group differences (Hernandez et al., 2010).
Open Field Test
The device is based on a square field (50 × 50 × 30 cm). A lamp was located 150 cm above the field, and the illumination of the central area was approximately 100 lux. At the beginning of each experiment, a mouse was placed in a 15 × 15 cm central area. At the beginning of the experiment, each mouse was placed in the center of the field, and the time spent in the central area within 10 min was recorded.
Immune Reconstitution (IR)
Harvested mouse spleens were digested and washed with phosphate buffered saline (Thermo Fisher Scientific, Waltham, MA, United States). Then, splenocytes were obtained by removing the red blood cells with lysis buffer (BD Biosciences, San Jose, CA, United States) and filtering through a 70 μm cell strainer (Jet Biofil, Guangzhou, China). Then, 3 × 105 splenocytes were administered via the tail vein (McDermott et al., 2010).
Cortical Cerebral Blood Flow Measurements
Images were acquired with a laser speckle contrast imager (PeriCam PSI System, Perimed, Stockholm, Sweden). We used the PeriCam PSI HD system to calculate an arbitrary index of cerebral blood flow (perfusion units) in the ipsilateral hemisphere.
Cell Preparation and Flow Cytometric Analysis
Harvested mouse spleens were macerated and washed with phosphate buffer saline (Thermo Fisher Scientific, Waltham, MA, United States). Then, splenocytes were obtained by removing the red blood cells with lysis buffer (BD Biosciences, San Jose, CA, United States) and filtering through a 70 μm cell strainer (Jet Biofil, Guangzhou, China). Additionally, fresh blood samples were collected in heparinized tubes. T (CD3+) cells, B (CD3–CD45R/B220+) cells, and NK (CD3–CD49b+) cells in the spleen and blood were directly quantified using flow cytometry (Beckman FC-500, Miami, FL, United States).
Some splenocytes were cultured with added GA in 6-well plates for 36 h. Then effector T (CD45+CD3+CD44+CD62l–) cells, and effector B (CD45+CD3–CD45R/B220+CD138+CD27+) cells were directly quantified using flow cytometry. All antibodies were used at an optimized working concentration of 1 μg/ml.
Immunofluorescence Images
Brain tissue was collected from mice following treatment with GA. Brain tissue was fixed with 4% paraformaldehyde (PFA) in 0.1 M phosphate-buffered saline (PBS) overnight, followed by a 15–30% sucrose gradient dehydration for 1 day until the brain had completely sunk to the bottom of the sucrose solution. An optimal cutting temperature compound was used to embed tissue samples. Successive coronal sections of 10 μm were cut using a freezing microtome. Tissue slices were washed with PBS and blocked for 1 h (in 10% bovine serum albumin, 3% normal donkey serum, and 1% Triton X-100 in PBS) and mounted on tissue slides. Antibodies against Nestin and SOX2 (Abcam, Cambridge, MA, United States), which can be used to label quiescent radial-glia-like type I neural progenitor cells (Encinas et al., 2011), were used. The next day, the slides were washed three times and incubated with the appropriate Alexa 488- and Alexa 568- secondary antibodies (Thermo Fisher Scientific) for 1 h at room temperature (1:1,000 dilution). DAPI staining was used to label nuclei. Slides were examined using an OLYMPUS BX53 microscope (Olympus, Madison, WI).
RNA Sequencing Analysis
RNA sequencing was performed independently and uniformly for each sample. GA- and control-treated mice were anesthetized and euthanized, and two blood samples were removed for RNA-seq following extraction of total RNA. Clean reads were aligned to the reference gene sequence using bowtie-2, and the gene expression levels of each sample were calculated. DEG detection was conducted using the DEGseq method. The statistical results were based on the ma-plot method. The number of reads of specific genes obtained from the sample was sampled randomly, and then P-values were calculated according to the normal distribution and corrected to q-values. To improve the accuracy of DEG detection, genes with a difference multiple of more than twice, and a q ≤ 0.001 were screened and defined as significantly differentially expressed genes.
Statistical Analysis
Statistical analysis of data was conducted using Graphpad Prism 5.0 and expressed as the mean ± standard error of the mean (SEM). Statistical comparisons of two groups were made using the unpaired t-test. Escape latency of six consecutive daily tests used the repeated measures ANOVA. Probability values less than 0.05 were considered statistically significant.
Results
GA Prevented Impairments of Learning and Memory Displayed and Improved CBF in Middle-Aged C57BL/6 Mice
Twelve-month-old female C57BL/6 mice were injected with GA (5 mg/kg, once every other day, tail intravenous injection, i.v.) for 6 weeks. Then, we tested the behavioral effects of GA using the Morris water maze (MWM) task to evaluate spatial learning and memory. The MWM showed that the GA-treated mouse latencies to the platform gradually decreased compared with the control after 6 days of training (Figure 1B). In the training test, the test results for the main effect of time, age are respectively, F = 45.34, P < 0.001 and F = 4.569, P = 0.0451. The interaction effects were not statistically significant (P = 0.6212). The impairment in learning and memory displayed in middle-aged mice can be prevented by GA treatment as indicated by decreased escape latencies (Figure 1C), more time in the target quadrant (Figure 1D), and increased platform crossings (Figure 1E). This effect was accompanied by improved cerebral blood flow (CBF) (Figures 1F,G). Both the control and GA groups exhibited similar swim speeds to the virtual platform (Supplementary Figure S1). These data suggested that GA improved CBF and prevented impairments of learning and memory displayed in middle-aged C57BL/6 mice.
GA-Treatment Actived T/B Genes Expression in the Blood RNA-Seq
We analyzed the transcriptome of C57BL/6 mice blood using RNA-seq. There were 940 differentially expressed genes between the GA and control groups, of which 81 were upregulated and 859 were downregulated (Figure 2A). KEGG pathway analysis also demonstrated that GA significantly influenced the hematopoietic cell lineage (Figure 2B). Furthermore, gene set enrichment analysis of these differentially expressed genes revealed that GA treatment activated the hematopoietic cell lineage (Figure 2C). The differential genes in the pathway were clustered using heat mapping (Figure 2D). The RNA-seq results showed that GA activated CD8a, Fcer2a (CD23), and Cr2 (CD21) expression and that it inhibits the expressions of macrophage and neutrophil-related genes.
GA-Treatment Increased T/B Cell Numbers in the Blood and Spleen
To further verify the relationships of the active genes to cognitive ability, we analyzed the levels of CD3e+ T cells, CD45R/B220+ B cells, and CD49b+ NK cells in the blood and spleen after 42 days of GA treatment. Flow cytometry results showed that GA could increase T and B cell numbers in the blood and spleen (Figures 3A,B), whereas NK cell numbers were unchanged in the spleen (Figure 3C).
To demonstrate that GA produces the similar effects in vitro, we used GA-treated single cells obtained from 8-week-old C57BL/6 mouse spleens for 36 h and measured the changes of T and B cells. Flow cytometry showed that GA could significantly increase the numbers of T and B cells in vitro (Figure 3D). Quantitative real-time PCR showed that CD3e and CD45R/B220 genes are overexpressed (Figures 3E,F). We treated T cells and B cells obtained from 8-week-old C57BL/6 mouse spleens using flow cytometry sorting with 50 μM GA and respectively measured effector T cells (CD45+CD3–CD45R/B220+CD138+CD27+) and effector B cells (CD45+CD3+CD44+CD62l–). The results showed that GA could increase effector cells in vitro (Figures 3G,H). These results showed that GA increased T and B cells in vivo and in vitro.
GA Improved Cognitive Levels by Regulating T/B Cell Proliferation
To further investigate whether the neuroprotective effects of GA were related to the T and B cells, we used B-NDG (NOD-Prkdscid IL2rgtm1/Bcgen) mice (Supplementary Figure S2), which lack T, B, and NK cells. We tested behavioral effects after immune reconstitution (IR) and IR + GA treatment by performing a novel object recognition task to measure the attention and non-spatial declarative memory in B-NDG mice. Before the novel object recognition task, we performed the open field test to evaluate the anxiety behavior of these mice. Anxiety levels can be determined based upon the time the mice remain in the corner of the enclosure. We found that the ratio of the time the IR + PBS and IR + GA mice spent in the center of the enclosure to the time spent in a corner over a 10 min test session was not significantly different compared with the control group (Figure 4A). The novel object recognition task showed that IR + PBS mice exhibited a significant preference for object exploration (Figure 4B). After IR, the GA treatment showed a more significant preference when contrasted with PBS treatment (Figure 4B).
We analyzed the levels of CD3e+ positive T cells, CD45R/B220+ positive B cells, and CD49b+ positive NK cells in the blood and spleen (Supplementary Figure S3). Flow cytometry results showed that the IRs of B-NDG mice were successful given that T, B, and NK cells in IR + PBS mice were significantly increased compared with controls (Figures 4C,E and Supplementary Figure S4). Thus, GA treatment after IR can increase the number of T and B cells compared with PBS treatment after IR (Figures 4C,E), whereas NK cell numbers were unchanged (Supplementary Figure S4). This result was consistent with those above from C57BL/6 mice. Furthermore, we measured the numbers of CD4 and CD8 cells in the spleen and found they were increased (Figure 4D), which was consistent with our RNA-sequencing results.
GA-Treatment Increased Neural Stem Cells in the Dentate Gyrus
To further investigate various mouse brain tissue characteristics, we examined the neural stem cell markers Nestin and SOX2 in the dentate gyrus (DG) of the hippocampus in IR + PBS, or IR + GA treated mice and control mice. The results showed that the numbers of Nestin + SOX2 + double-positive cells were significantly increased in the DG of immunologically reconstituted mice compared with the control and GA treatment, or compared with PBS injection after IR (Figures 5A,B).
Discussion
Our work has thus revealed that GA treatment can revitalize the aging brain and alleviate aging-associated cognitive declines and that these effects may be related to the immune system. RNA-seq data demonstrated the effect of GA on hematopoietic cell lineage, and we posited that GA could enhance cognition through immune system modulation. We observed lymphocyte changes in C57BL/6 mice, then used B-NDG mice to verify further the importance of the immune system in cognitive ability. The B-NDG mice exhibit a severe immunodeficiency phenotype with no mature T cells, B cells, or functional NK cells and a lack of cytokine signaling ability. The results of the novel object recognition task confirmed our hypothesis; after IR, cognitive ability was improved (Figure 4B).
A marked increase in the number of cytotoxic CD4 T cells (CD4 cytotoxic T lymphocytes) is a signature characteristic of supercentenarians (Hashimoto et al., 2019). We observed that CD4+ T cells were significantly expanded in number (Figure 4D), but we cannot confirm whether these represent cytotoxic CD4 T cells. Although we did not investigate immune responses in the brain, many studies have demonstrated the role of CD4 T cells in neuroinflammatory and neurodegenerative processes (Brochard et al., 2009; Baruch et al., 2015; Dansokho et al., 2016). Pasciuto showed that absence of the CD4 T cell population resulted in microglia remaining suspended between a fetal and adult developmental state, resulting in defects in synaptic pruning function and normal mouse behavior (Pasciuto et al., 2020). Additionally, microglial regeneration was found to improve spatial learning ability and promote hippocampal nerve regeneration (Willis et al., 2020). We hypothesized that GA affects cognition by acting on immune cells in the blood and brain, further influencing microglia in the mouse brain, which requires further study.
The brain is particularly susceptible to the effects of aging, and aging-associated inflammation is a major risk factor for a variety of neurocognitive and neurodegenerative diseases (Fung et al., 2020). There are abnormal neural stem cells, neurons, and microbes in the brain, and their clearance by immune cells can preserve cognitive function (Bussian et al., 2018). Further efforts to understand the effector cells in this process and how these events occur would be worthwhile in understanding the roles of immune cells in brain aging.
During cytokine storms, cytokine levels are abnormally high, which can lead to fever, low blood pressure, and heart problems and, in some cases, organ failure and death (RIddell, 2018). Bacterial infection and viruses such as SARS (severe acute respiratory syndrome) and MERS (Middle East respiratory syndrome) can cause cytokine storms, which attack host cells, mainly the patient’s immune cells (Tisoncik et al., 2012). Macrophages and neutrophils are known to produce catecholamines in response to inflammatory stimuli such as lipopolysaccharide (LPS), which is a hallmark of many types of bacterial infection (Flierl et al., 2007). Our RNA-seq results showed that GA treatment could inhibit several genes related to macrophages, neutrophils, and IL1β (Supplementary Figure S1). This finding indicates that GA might inhibit the proliferation of macrophages and neutrophils from preventing cytokine storms. Treatment with GA can also alleviate β-amyloid (Ahn et al., 2006; Zhao et al., 2013) or systemic LPS-induced (Song et al., 2013) cognitive impairment via inhibition of neuroinflammation. Some COVID-19 patients have been alleviated symptoms using diammonium glycyrrhizinate, an ammonium salt preparation of 18-alpha-GA (Ding et al., 2020; Li et al., 2020). This phenomenon could be explained by the anti-inflammatory properties of GA. In conclusion, the potential effects of GA treatments on memory and behavior, longevity, and anti-viral activity may be worthy of future investigation.
Data Availability Statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ncbi.nlm.nih.gov/, GSE146239.
Ethics Statement
The animal study was reviewed and approved by the Animal Research Committee of Tongji University School of Medicine, China.
Author Contributions
RJ, JG, JS, XZ, HW, SF, and CH performed the experiments. RJ and HL analyzed the data and prepared the manuscript. HL and HS supervised the project. HL designed the project. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
This manuscript has been released as a pre-print at bioRxiv (Jiang et al., 2020).
Footnotes
Funding. This work was supported by grants from the National Key Research and Development Program (No. 2020YFC2002800), National Natural Science Foundation of China (Grant Nos. 31671539 and 31370214), and Major Program of Development Fund for Shanghai Zhangjiang National Innovation Demonstration Zone <Stem Cell Strategic Biobank and Stem Cell Clinical Technology Transformation Platform> (No. ZJ2018-ZD-004), and the Oasis Scholars Support Program of Shihezi University (to HL).
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnagi.2020.570116/full#supplementary-material
References
- Ahn J., Um M., Choi W., Kim S., Ha T. (2006). Protective effects of Glycyrrhiza uralensis Fisch. on the cognitive deficits caused by beta-amyloid peptide 25-35 in young mice. Biogerontology 7 239–247. 10.1007/s10522-006-9023-0 [DOI] [PubMed] [Google Scholar]
- Bach M. E., Barad M., Son H., Zhuo M., Lu Y. F., Shih R., et al. (1999). Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proc. Natl. Acad. Sci. U.S.A. 96 5280–5285. 10.1073/pnas.96.9.5280 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Baruch K., Rosenzweig N., Kertser A., Deczkowska A., Sharif A. M., Spinrad A., et al. (2015). Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer’s disease pathology. Nat. Commun. 6:7967. 10.1038/ncomms8967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brochard V., Combadière B., Prigent A., Laouar Y., Perrin A., Beray-Berthat V., et al. (2009). Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J. Clin. Invest. 119 182–192. 10.1172/JCI36470 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bussian T. J., Aziz A., Meyer C. F., Swenson B. L., van Deursen J. M., Baker D. J. (2018). Clearance of senescent glial cells prevents tau-dependent pathology and cognitive decline. Nature 562 578–582. 10.1038/s41586-018-0543-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dansokho C., Ait Ahmed D., Aid S., Toly-Ndour C., Chaigneau T., Calle V., et al. (2016). Regulatory T cells delay disease progression in Alzheimer-like pathology. Brain J. Neurol. 139 1237–1251. 10.1093/brain/awv408 [DOI] [PubMed] [Google Scholar]
- Ding H., Deng W., Ding L., Ye X., Yin S., Huang W. (2020). Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients. J. Med. Virol. 92 2200–2204. 10.1002/jmv.26064 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Encinas J. M., Michurina T. V., Peunova N., Park J. H., Tordo J., Peterson D. A., et al. (2011). Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus. Cell Stem Cell 8 566–579. 10.1016/j.stem.2011.03.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Flierl M. A., Rittirsch D., Nadeau B. A., Chen A. J., Sarma J. V., Zetoune F. S., et al. (2007). Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 449 721–725. 10.1038/nature06185 [DOI] [PubMed] [Google Scholar]
- Frick K. M., Burlingame L. A., Arters J. A., Berger-Sweeney J. (2000). Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience 95 293–307. 10.1016/s0306-4522(99)00418-2 [DOI] [PubMed] [Google Scholar]
- Fung I. T. H., Sankar P., Zhang Y., Robison L. S., Zhao X., D’Souza S. S., et al. (2020). Activation of group 2 innate lymphoid cells alleviates aging-associated cognitive decline. J. Exp. Med. 217:e20190915. 10.1084/jem.20190915 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gong G., Yuan L. B., Hu L., Wu W., Yin L., Hou J. L., et al. (2012). Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1. Acta Pharmacol. Sin. 33 11–18. 10.1038/aps.2011.151 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hashimoto K., Kouno T., Ikawa T., Hayatsu N., Miyajima Y., Yabukami H., et al. (2019). Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians. Proc. Natl. Acad. Sci. U.S.A. 116 24242–24251. 10.1073/pnas.1907883116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hernandez C. M., Kayed R., Zheng H., Sweatt J. D., Dineley K. T. (2010). Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer’s disease. J. Neurosci. 30 2442–2453. 10.1523/JNEUROSCI.5038-09.2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jiang R., Gao J., Shen J., Zhu X., Wang H., Feng S., et al. (2020). Glycyrrhizic acid improves cognitive levels of aging mice by regulating T/B cell proliferation. bioRxiv [Preprint]. 10.1101/2020.03.25.008821 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim S. W., Jin Y., Shin J. H., Kim I. D., Lee H. K., Park S., et al. (2012). Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion. Neurobiol. Dis. 46 147–156. 10.1016/j.nbd.2011.12.056 [DOI] [PubMed] [Google Scholar]
- Li R., Wu K., Li Y., Liang X., Lai K. P., Chen J. (2020). Integrative pharmacological mechanism of vitamin C combined with glycyrrhizic acid against COVID-19: findings of bioinformatics analyses. Brief. Bioinform. bbaa141. 10.1093/bib/bbaa141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- McDermott S. P., Eppert K., Lechman E. R., Doedens M., Dick J. E. (2010). Comparison of human cord blood engraftment between immunocompromised mouse strains. Blood 116 193–200. 10.1182/blood-2010-02-271841 [DOI] [PubMed] [Google Scholar]
- Pasciuto E., Burton O. T., Roca C. P., Lagou V., Rajan W. D., Theys T., et al. (2020). Microglia require CD4 T cells to complete the fetal-to-adult transition. Cell 182 625–640.e24. 10.1016/j.cell.2020.06.026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- RIddell S. R. (2018). Adrenaline fuels a cytokine storm during immunotherapy. Nature 564 194–196. 10.1038/d41586-018-07581-w [DOI] [PubMed] [Google Scholar]
- Shoji H., Takao K., Hattori S., Miyakawa T. (2016). Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age. Mol. Brain 9:11 10.1186/s13041-016-0191-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Song J. H., Lee J. W., Shim B., Lee C. Y., Choi S., Kang C., et al. (2013). Glycyrrhizin alleviates neuroinflammation and memory deficit induced by systemic lipopolysaccharide treatment in mice. Molecules 18 15788–15803. 10.3390/molecules181215788 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taglialatela G., Hogan D., Zhang W. R., Dineley K. T. (2009). Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav. Brain Res. 200 95–99. 10.1016/j.bbr.2008.12.034 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Teng L., Kou C., Lu C., Xu J., Xie J., Lu J., et al. (2014). Involvement of the ERK pathway in the protective effects of glycyrrhizic acid against the MPP+-induced apoptosis of dopaminergic neuronal cells. Int. J. Mol. Med. 34 742–748. 10.3892/ijmm.2014.1830 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tisoncik J. R., Korth M. J., Simmons C. P., Farrar J., Martin T. R., Katze M. G. (2012). Into the eye of the cytokine storm. Microbiol. Mol. Biol. Rev. 76 16–32. 10.1128/MMBR.05015-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang C., Chen L., Xu C., Shi J., Chen S., Tan M., et al. (2020). A comprehensive review for phytochemical, pharmacological, and biosynthesis studies on Glycyrrhiza spp. Am. J. Chin. Med. 48 17–45. 10.1142/S0192415X20500020 [DOI] [PubMed] [Google Scholar]
- Willis E. F., MacDonald K., Nguyen Q. H., Garrido A. L., Gillespie E. R., Harley S., et al. (2020). Repopulating microglia promote brain repair in an IL-6-dependent manner. Cell 180 833–846.e16. 10.1016/j.cell.2020.02.013 [DOI] [PubMed] [Google Scholar]
- Zhang J. B., Chen L., Lv Z. M., Niu X. Y., Shao C. C., Zhang C., et al. (2016). Oxytocin is implicated in social memory deficits induced by early sensory deprivation in mice. Mol. Brain 9:98. 10.1186/s13041-016-0278-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhao H., Wang S. L., Qian L., Jin J. L., Li H., Xu Y., et al. (2013). Diammonium glycyrrhizinate attenuates Abeta(1-42) -induced neuroinflammation and regulates MAPK and NF-kappaB pathways in vitro and in vivo. CNS Neurosci. Ther. 19 117–124. 10.1111/cns.12043 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found below: https://www.ncbi.nlm.nih.gov/, GSE146239.